COMP <GO>
SLVM vs FCX // REVENUE GROWTH (YOY)
Sylvamo Corporation (NYSE) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: SLVM 5
— FCX 6
▲ REVENUE GROWTH (YOY) LEADER: FCX
LAST: $32.32 (+1.32%) • MKT CAP: $1.29B
revenue-growth
-11.20%
LAST: $66.14 (-0.69%) • MKT CAP: $94.98B
revenue-growth
0.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SLVM VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SLVM | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 26.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.50% | 21.50% | -1.00 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.1x | 13.4x | -8.30 | SLVM | /valuation <GO> |
| Free Cash Flow Yield | 20.86% | 4.71% | +16.15 | SLVM | /fcf-yield <GO> |
| Operating Margin | 7.50% | 25.90% | -18.40 | FCX | /operating-margins <GO> |
| Net Profit Margin | 3.90% | 8.80% | -4.90 | FCX | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -11.20% | 0.10% | -11.30 | FCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.68% | 0.91% | +4.77 | SLVM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.08 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 43.5 | +2.00 | SLVM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.0x | 40.1x | -31.10 | SLVM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.29B | $94.98B | -$93.69B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SLVM REV | FCX REV | SLVM GROSS % | FCX GROSS % | SLVM FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.35B | $25.19B | — | 26.1% | $268.0M | $4.48B |
| FY 2024 | $3.77B | $25.17B | — | 29.3% | $469.0M | $6.03B |
| FY 2023 | $3.72B | $22.70B | — | — | $504.0M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SLVM // BETA —
FCX // BETA 0.95